Search

Your search keyword '"Shingarev, Roman"' showing total 44 results
Start Over Author "Shingarev, Roman"
44 results on '"Shingarev, Roman"'

1. Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Published
2023
Full Text
View/download PDF

2. Approach to a Nonfunctioning Catheter

Author

Shingarev, Roman, Yevzlin, Alexander S., Yevzlin, Alexander S., editor, Asif, Arif, editor, Salman, Loay, editor, Ramani, Karthik, editor, Qaqish, Shaker S., editor, and Vachharajani, Tushar J., editor

Published
2022
Full Text
View/download PDF

7. Additional file 2 of Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Abstract

Supplementary Material 2

Published
2023
Full Text
View/download PDF

8. Additional file 8 of Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Abstract

Supplementary Material 8

Published
2023
Full Text
View/download PDF

9. sj-pdf-1-jva-10.1177_11297298231159251 – Supplemental material for Global hemodialysis vascular access care: Three decades of evolution*

Author

Hassanein, Mohamed, Radhakrishnan, Yeshwanter, Hernandez Garcilazo, Nora, Khor, Si Yuan, Norouzi, Sayna, Anvari, Evamaria, Shingarev, Roman, and Vachharajani, Tushar J

Subjects
Cardiology
Abstract

Supplemental material, sj-pdf-1-jva-10.1177_11297298231159251 for Global hemodialysis vascular access care: Three decades of evolution* by Mohamed Hassanein, Yeshwanter Radhakrishnan, Nora Hernandez Garcilazo, Si Yuan Khor, Sayna Norouzi, Evamaria Anvari, Roman Shingarev and Tushar J Vachharajani in The Journal of Vascular Access

Published
2023
Full Text
View/download PDF

10. sj-docx-1-jva-10.1177_11297298231159251 – Supplemental material for Global hemodialysis vascular access care: Three decades of evolution*

Author

Hassanein, Mohamed, Radhakrishnan, Yeshwanter, Hernandez Garcilazo, Nora, Khor, Si Yuan, Norouzi, Sayna, Anvari, Evamaria, Shingarev, Roman, and Vachharajani, Tushar J

Subjects
Cardiology
Abstract

Supplemental material, sj-docx-1-jva-10.1177_11297298231159251 for Global hemodialysis vascular access care: Three decades of evolution* by Mohamed Hassanein, Yeshwanter Radhakrishnan, Nora Hernandez Garcilazo, Si Yuan Khor, Sayna Norouzi, Evamaria Anvari, Roman Shingarev and Tushar J Vachharajani in The Journal of Vascular Access

Published
2023
Full Text
View/download PDF

11. Additional file 7 of Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Abstract

Supplementary Material 7

Published
2023
Full Text
View/download PDF

12. Additional file 3 of Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Abstract

Supplementary Material 3

Published
2023
Full Text
View/download PDF

13. Additional file 1 of Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Abstract

Supplementary Material 1

Published
2023
Full Text
View/download PDF

14. Additional file 6 of Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Abstract

Supplementary Material 6

Published
2023
Full Text
View/download PDF

15. Additional file 5 of Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial

Author

Murea, Mariana, Gardezi, Ali I., Goldman, Mathew P., Hicks, Caitlin W., Lee, Timmy, Middleton, John P., Shingarev, Roman, Vachharajani, Tushar J., Woo, Karen, Abdelnour, Lama M., Bennett, Kyla M., Geetha, Duvuru, Kirksey, Lee, Southerland, Kevin W, Young, Carlton J., Brown, William M., Bahnson, Judy, Chen, Haiying, and Allon, Michael

Abstract

Supplementary Material 5

Published
2023
Full Text
View/download PDF

27. PD41-10 PHASE III TRIAL OF INTRAVENOUS MANNITOL VERSUS PLACEBO DURING NEPHRON SPARING SURGERY: 3-YEAR OUTCOMES

Author

Wong*, Nathan C., primary, Alvim, Ricardo G., additional, Sjoberg, Daniel D., additional, Shingarev, Roman, additional, Power, Nicholas E., additional, Spaliviero, Maximillian, additional, Murray, Katie S., additional, Benfante, Nicole E., additional, Hakimi, A. Ari, additional, Russo, Paul, additional, and Coleman, Jonathan A., additional

Published
2019
Full Text
View/download PDF

28. Kidney Complications of Immune Checkpoint Inhibitors: A Review

Author

Shingarev, Roman and Glezerman, Ilya G.

Abstract

Immunologic control of malignancy has long been recognized as an important determinant of disease progression. Recent advances in immunology have led to the focus on several mechanisms that can be targeted to achieve tumor suppression. In particular, checkpoint inhibition has evolved in less than a decade to become one of the most important strategies in cancer therapy, with a meaningful improvement in patient survival. Six agents have been approved for clinical use to date and many more are in the industry pipeline. The spectrum of malignancies responsive to immunotherapy ranges from advanced melanoma, for which the first immune checkpoint inhibitor ipilimumab was approved, to Hodgkin lymphoma, non–small cell lung cancer, renal cell carcinoma, and others. Notwithstanding its clinical benefits, checkpoint inhibition carries a risk for significant off-target toxicity stemming from the immune system activation. In this review, we discuss general principles of checkpoint inhibition, mechanisms of toxicity, and kidney complications of the treatment and propose diagnostic and treatment strategies when kidney injury occurs.

Published
2024
Full Text
View/download PDF

29. Global hemodialysis vascular access care: Three decades of evolution*

Author

Hassanein, Mohamed, Radhakrishnan, Yeshwanter, Hernandez Garcilazo, Nora, Khor, Si Yuan, Norouzi, Sayna, Anvari, Evamaria, Shingarev, Roman, and Vachharajani, Tushar J

Abstract

The development of vascular access for hemodialysis has come a long way since 1943 when the first hemodialysis treatment was performed in humans by connecting an artery and vein using an external glass canula. Since then, vascular access care has evolved robustly through contributions from numerous countries and professional nephrology societies, worldwide. To understand the global distribution and contribution of different specialties to medical literature on dialysis vascular access care, we performed a literature search from 1991 to 2021 and identified 2768 articles from 74 countries. The majority of publications originated from the United States (41.5%), followed by China (5.1%) and the United Kingdom (4.6%). Our search results comprise of observational studies (43%), case reports/series (27%), review articles (16.5%) and clinical trials (12%). A large proportion of articles were published in Nephrology journals (49%), followed by General Medicine (14%), Surgery (10%), Vascular Medicine (8%), and Interventional Radiology journals (4%). With the introduction of interventional nephrology, nephrologists will be able to assume the majority of the responsibility for dialysis vascular access care and above all maintain a close interdisciplinary collaboration with other specialties to provide optimum patient care. In this review article, we discuss the history, evolving knowledge, challenges, educational opportunities, and future directions of dialysis vascular access care, worldwide.

Published
2024
Full Text
View/download PDF

32. Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients

Author

Rosenzweig, Barak, primary, Rubinstein, Nimrod D., additional, Reznik, Ed, additional, Shingarev, Roman, additional, Juluru, Krishna, additional, Akin, Oguz, additional, Hsieh, James J., additional, Jaimes, Edgar A., additional, Russo, Paul, additional, Susztak, Katalin, additional, Coleman, Jonathan A., additional, and Hakimi, A. Ari, additional

Published
2017
Full Text
View/download PDF

33. MP73-17 BENIGN AND TUMOR PARENCHYMA METABOLOMIC PROFILES AFFECT COMPENSATORY RENAL GROWTH IN RENAL CELL CARCINOMA SURGICAL PATIENTS

Author

Rosenzweig, Barak, primary, Rubinstein, Nimrod Daniel, additional, Reznik, Ed, additional, Zareba, Piotr, additional, Shingarev, Roman, additional, Juluru, Krishna, additional, Akin, Oguz, additional, Hsieh, James J, additional, Jaimes, Edgar, additional, Russo, Paul, additional, Susztak, Katalin, additional, Coleman, Jonathan A, additional, and Hakimi, A Ari, additional

Published
2017
Full Text
View/download PDF

34. Effect of benign and tumor parenchyma metabolomic profiles on compensatory renal growth in renal cell carcinoma surgical patients.

Author

Rosenzweig, Barak, primary, Rubinstein, Nimrod Daniel, additional, Reznik, Eduard, additional, Zareba, Piotr, additional, Shingarev, Roman, additional, Juluru, Krishna, additional, Akin, Oguz, additional, Hsieh, James, additional, Jaimes, Edgar A, additional, Russo, Paul, additional, Susztak, Katalin, additional, Coleman, Jonathan, additional, and Hakimi, A. Ari, additional

Published
2017
Full Text
View/download PDF

36. MP85-20 METABOLOMICS AND POST-NEPHRECTOMY RENAL FUNCTION PREDICTION

Author

Rosenzweig, Barak, primary, Reznik, Ed, additional, Shingarev, Roman, additional, Zabor, Emily C, additional, Stirdivant, Steven, additional, Sander, Chris, additional, Hsieh, James J., additional, Jaimes, Edgar A, additional, Russo, Paul, additional, Hakimi, A Ari, additional, and Coleman, Jonathan A., additional

Published
2016
Full Text
View/download PDF

38. Renal cell carcinoma: new insights and challenges for a clinician scientist.

Author

Shingarev, Roman and Jaimes, Edgar A.

Abstract

There is a growing recognition of the complex interplay between renal cell cancer (RCC), kidney function, mechanical reduction of nephron mass, and systemic agents targeting the cancer. Earlier detection of RCC and rising life expectancy of cancer survivors places a greater emphasis on preservation of renal function after cancer resection and during systemic therapy. Unique adverse effects associated with RCC drugs not only help reveal cancer pathophysiology but also expand our knowledge of normal cell signaling and metabolism. In this review, we outline our current understanding of RCC biology and treatment, their bidirectional relationship with kidney function, and unmet research needs in this field. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

43. Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Coprescribed Serotonin Receptor Antagonists: A Retrospective Analysis.

Author

Gutgarts V, Gerardine S, Shingarev RA, Knezevic A, Zabor EC, Latcha S, Joy MS, Aleksunes LM, and Jaimes EA

Subjects
Humans, Retrospective Studies, Male, Female, Middle Aged, Antineoplastic Agents adverse effects, Aged, Adult, Acute Kidney Injury chemically induced, Cisplatin adverse effects, Serotonin Antagonists adverse effects, Serotonin Antagonists therapeutic use
Published
2024
Full Text
View/download PDF

44. Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.

Author

Silverstein DM, Trerotola SO, Clark T, James G, Ng W, Dwyer A, Florescu MC, Shingarev R, and Ash SR

Subjects
Central Venous Catheters adverse effects, Equipment Design, Humans, Risk Assessment, Central Venous Catheters standards, Renal Dialysis instrumentation
Abstract

Central venous catheters remain a vital option for access for patients receiving maintenance hemodialysis. There are many important and evolving clinical and regulatory considerations for all stakeholders for these devices. Innovation and transparent and comprehensive regulatory review of these devices is essential to stimulate innovation to help promote better outcomes for patients receiving maintenance hemodialysis. A workgroup that included representatives from academia, industry, and the US Food and Drug Administration was convened to identify the major design considerations and clinical and regulatory challenges of central venous catheters for hemodialysis. Our intent is to foster improved understanding of these devices and provide the foundation for strategies to foster innovation of these devices., (Copyright © 2018 by the American Society of Nephrology.)

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results